anti etv5 (Cell Signaling Technology Inc)
Structured Review
Anti Etv5, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+etv5/ETV5+Rabbit+mAb/pm41791643-77-22-24
Average 94 stars, based on 10 article reviews
Images
Related Articles
other:Article Title: ETV5 transcriptionally activates TGFβ1 and promotes cancer cell invasion and migration of NSCLC. Article Snippet: Non-small cell lung cancer (NSCLC), which mainly includes lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), consists 85% of lung cancer worldwide (Yang et al. 2022).. Despite tremendous efforts had been made in diagnosis and treatment of lung cancer, an estimated 1.7 million people die of lung cancer each year (Bray et al. 2018).. Moreover, lung cancer is a heterogeneous disease at the molecular level. Article Title: First Generation Tools for the Modeling of Capicua (CIC) - Family Fusion Oncoprotein-Driven Cancers Article Snippet: Antibodies and dilutions or concentrations used were: Chromatin Immunoprecipitation:Article Title: ERRα-ETV5 axis drives PD-L1 upregulation and immune escape in gallbladder cancer. Article Snippet: Gallbladder cancer (GBC) is a highly aggressive malignancy with a poor response to immune checkpoint blockade (ICB), highlighting an urgent need to understand the mechanisms of immune evasion.. We identified the orphan nuclear receptor ERRα as a critical regulator of the immunosuppressive tumor microenvironment in GBC.. Mechanistically, we discovered that ERRα transcriptionally upregulates the ETS-family transcription factor ETV5, which in turn directly binds to and activates the PD-L1 (CD274) promoter, establishing a novel ERRαETV5-PD-L1 signaling axis. |
